RYDE GROUP LTD-A (RYDE)

KYG7733R1020 - Common Stock

0.515  +0.01 (+1.98%)

After market: 0.5 -0.02 (-2.91%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RYDE. RYDE was compared to 37 industry peers in the Ground Transportation industry. While RYDE seems to be doing ok healthwise, there are quite some concerns on its profitability. RYDE does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RYDE has reported negative net income.
In the past year RYDE has reported a negative cash flow from operations.

1.2 Ratios

RYDE has a worse Return On Assets (-328.07%) than 97.30% of its industry peers.
RYDE has a worse Return On Equity (-820.83%) than 89.19% of its industry peers.
Industry RankSector Rank
ROA -328.07%
ROE -820.83%
ROIC N/A
ROA(3y)-131.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 32.62%, RYDE is not doing good in the industry: 62.16% of the companies in the same industry are doing better.
RYDE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

RYDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
RYDE has less shares outstanding than it did 1 year ago.
RYDE has a better debt/assets ratio than last year.

2.2 Solvency

RYDE has an Altman-Z score of -12.31. This is a bad value and indicates that RYDE is not financially healthy and even has some risk of bankruptcy.
RYDE has a Altman-Z score of -12.31. This is amonst the worse of the industry: RYDE underperforms 91.89% of its industry peers.
RYDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.31
ROIC/WACCN/A
WACC8.07%

2.3 Liquidity

RYDE has a Current Ratio of 1.49. This is a normal value and indicates that RYDE is financially healthy and should not expect problems in meeting its short term obligations.
RYDE's Current ratio of 1.49 is amongst the best of the industry. RYDE outperforms 86.49% of its industry peers.
A Quick Ratio of 1.49 indicates that RYDE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.49, RYDE belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49

More info and screens

3

3. Growth

3.1 Past

The earnings per share for RYDE have decreased strongly by -219.70% in the last year.
The Revenue has decreased by -7.21% in the past year.
EPS 1Y (TTM)-219.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-293.06%
Revenue 1Y (TTM)-7.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.36%

3.2 Future

Based on estimates for the next years, RYDE will show a very strong growth in Earnings Per Share. The EPS will grow by 31.50% on average per year.
Based on estimates for the next years, RYDE will show a very strong growth in Revenue. The Revenue will grow by 30.92% on average per year.
EPS Next Y70.84%
EPS Next 2Y31.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year40.61%
Revenue Next 2Y30.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RYDE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RYDE's earnings are expected to grow with 31.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.5%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RYDE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RYDE GROUP LTD-A

NYSEARCA:RYDE (1/3/2025, 8:04:00 PM)

After market: 0.5 -0.02 (-2.91%)

0.515

+0.01 (+1.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)10-23 2024-10-23/bmo
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners5.21%
Ins Owner ChangeN/A
Market Cap13.54M
Analysts82.86
Price Target2.04 (296.12%)
Short Float %0.64%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-77.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 5.78
P/tB 7.44
EV/EBITDA N/A
EPS(TTM)-1.09
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.36
BVpS0.09
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -328.07%
ROE -820.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.62%
FCFM N/A
ROA(3y)-131.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 105.98%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z -12.31
F-Score4
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)133.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-293.06%
EPS Next Y70.84%
EPS Next 2Y31.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.36%
Revenue Next Year40.61%
Revenue Next 2Y30.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-268.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.03%
OCF growth 3YN/A
OCF growth 5YN/A